
- Applied Clinical Trials-12-01-2012
- Volume 21
- Issue 12
Optimizing Investigator Fees
Industry Standard Research
Awell documented 2008 study titled "Sensible Approaches for Reducing Clinical Trial Costs,"
But planners need to know when to offer more and when to offer less. Industry Standard Research has recently published a study that identifies the factors that drive investigator fees higher and lower and benchmarked these fees across 11 therapy areas.
Intuitively it makes sense that study length and complexity would both influence investigator fees. ISR's study quantified just how much. Investigators indicated that both study length and complexity have a dramatic impact on the amount of the investigator fees. For long and/or complex studies, investigator fees can run 50% to 60% higher than for more standard studies.
Knowing what levers push and pull investigator fees—and by how much—will help optimize the use of budgets industry wide and maybe even improve recruitment rates along the way.
—Industry Standard Research,
Articles in this issue
almost 13 years ago
Protocol Complexity Versus Patient Enrollmentalmost 13 years ago
Applied Clinical Trials Digital Edition - December 2012almost 13 years ago
Oh No Not Again...almost 13 years ago
Act coveralmost 13 years ago
Training and Educationalmost 13 years ago
Business and News Update December 2012almost 13 years ago
The Case for Universal GCP Educationalmost 13 years ago
Clinical Research in the New Economyalmost 13 years ago
DIA EuroMeeting Gets Set for 25th AnniversaryNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.